Gilead enters licensing pact with 5 drug firms in India, Pak for remdesivir
According to the agreement the companies Cipla, Hetero Labs, Jubilant Life Sciences, Mylan, and Pakistan based Ferozsons Labs, to manufacture and sell remdesivir in 127 countries
No comments:
Post a Comment